(Q46625058)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16052341%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16052341%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16052341%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Monika Jermann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16052341%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Rolf A Stahel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16052341%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Marc Salzberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16052341%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Thomas Cerny

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16052341%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Markus Joerger

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16052341%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Rudolf Morant

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16052341%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Fritz Egli

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16052341%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Kaspar Rhyner

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16052341%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Jean A Bauer

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16052341%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Miklos Pless

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16052341%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

29 July 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16052341%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

4 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16052341%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16052341%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

533-539

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16052341%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16052341%20AND%20SRC:MED&resulttype=core&format=json